Skip to content

Randomized trial of lower lung ligamentolysis versus nonolysis after lobectomy

Randomized trial of lower lung ligamentolysis versus nonolysis after lobectomy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076743
Enrollment
Unknown
Registered
2023-10-17
Start date
2023-11-01
Completion date
Unknown
Last updated
2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Experimental group (group A) : preserved inferior pulmonary ligament group
:Preserve the lower lung ligaments
Control group (group B) : lower lung ligament loosening group:Release the lower lung ligaments

Sponsors

Department of Thoracic Surgery, The First Affiliated Hospital of Jinan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) NSCLC patients eligible for thoracoscopic left/right upper lobectomy according to NCCN guidelines for lung cancer and exclusion of contraindications; (2) Age 1.5L or up to 5 flights of stairs after climbing test; (6) Preoperative ASA score I-II.

Exclusion criteria

Exclusion criteria: (1) Preoperative chest CT indicated lymph node enlargement in group 9, with no exception of metastasis; (2) Concurrent with other lung lobe nodules on the same side, other lung lobe operations should be performed simultaneously; (3) History of thoracic surgery (including intrathoracic surgery only, excluding body surface surgery such as mastectomy); (4) Preoperative history of chronic cough; (5) Preoperative history of pulmonary tuberculosis, bronchiectasis, COPD, asthma and other lung-related diseases; (6) A history of unstable angina pectoris or myocardial infarction within the past 3 months; (7) Have a history of cerebral infarction or cerebral hemorrhage within the past 3 months; (8) Intraoperative conversion to thoracotomy due to various reasons

Design outcomes

Primary

MeasureTime frame
Bronchial Angle;

Secondary

MeasureTime frame
Degree of pulmonary reexpansion;

Countries

China

Contacts

Public ContactSongwang Cai

Department of Thoracic Surgery, The First Affiliated Hospital of Jinan University

1105730906@qq.com+86 137 1081 4167

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026